F19.29
Other psychoactive substance dependence with unspecified psychoactive substance-induced disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.29 refers to a condition characterized by dependence on psychoactive substances other than those specifically classified. This diagnosis includes cases where individuals experience a substance-induced disorder, but the exact psychoactive substance involved cannot be precisely identified. Psychoactive substances affect the central nervous system, leading to changes in mood, perception, consciousness, and behavior. Dependence on these substances can significantly impact daily functioning and overall health. Recognizing and understanding this diagnosis is essential for healthcare providers and patients alike, to facilitate appropriate management and support.
Causes & Symptoms
Clinical Causes: Prolonged use of psychoactive substances such as certain medications, herbal supplements, or unidentified substances Repeated exposure to substances that have psychoactive properties, leading to physical or psychological dependence Underlying mental health issues that increase susceptibility to substance dependence Social and environmental factors, including peer pressure or availability of certain substances Genetic predisposition or family history of substance use disorders
Key Symptoms: Craving or a strong desire to use the substance An inability to control or reduce use despite awareness of negative effects Withdrawal symptoms when not using the substance, such as sweating, shakiness, anxiety, or nausea Neglect of responsibilities or commitments due to substance use Continued use despite physical, psychological, or social problems Tolerance, needing increased amounts of the substance to achieve the desired effect Social withdrawal or isolation Changes in mood, perception, or sleep patterns
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically made based on clinical assessment, history of substance use, and observed symptoms. Healthcare professionals may employ standardized screening tools, interviews, and laboratory tests to identify dependence and rule out other conditions. When the specific psychoactive substance is uncertain or unspecified, clinicians use the diagnostic code F19.29 to document the diagnosis. Accurate diagnosis is crucial for tailoring treatment plans and providing appropriate support.
Treatment Protocols: Management of this condition generally involves a combination of medical, psychological, and social interventions. Treatment strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is F19.29 a billable ICD-10 code?
Yes, F19.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.29?
Clinical documentation must specify the nature of Other psychoactive substance dependence with unspecified psychoactive substance-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference